AR246968A1 - Procedimiento y compuestos utiles como intermediarios,que no poseen actividad terapeutica en seres humanos y animales superiores,para la separacion de acidos oxoftalazinil-aceticos y sus analogos - Google Patents
Procedimiento y compuestos utiles como intermediarios,que no poseen actividad terapeutica en seres humanos y animales superiores,para la separacion de acidos oxoftalazinil-aceticos y sus analogosInfo
- Publication number
- AR246968A1 AR246968A1 AR90316824A AR31682490A AR246968A1 AR 246968 A1 AR246968 A1 AR 246968A1 AR 90316824 A AR90316824 A AR 90316824A AR 31682490 A AR31682490 A AR 31682490A AR 246968 A1 AR246968 A1 AR 246968A1
- Authority
- AR
- Argentina
- Prior art keywords
- alkyl
- formula
- analogs
- preparation
- acetic acids
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
- C07D237/30—Phthalazines
- C07D237/32—Phthalazines with oxygen atoms directly attached to carbon atoms of the nitrogen-containing ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
- C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Ophthalmology & Optometry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Abstract
PREPARACION DE ACIDOS OXOFTALAZINIL-ACETICOS Y SUS ANALOGOS DE FORMULA (I), DONDE X E Y SON CH O N; Z ES N O CR6; A ES UN ENLACE COVALENTE O C=O; R1 ES ALQUILO; R3 Y R4 SON HIDROGENO, FLUORO, CLORO, BROMO, TRIFLUOROMETILO, ALQUILO, ALCOXI, ALQUILTIO, ALQUILSULFINILO, ALQUILSULFONILO, O NITRO O BIEN R3 Y R4 ESTAN UNIDOS ENTRE SI Y SON ALCANODIOXI Y R5 Y R6 SON HIDROGENO, FLUORO, CLORO, BROMO, TRIFLUOROMETILO, NITRO CIANO, ALQUILO, ALCOXI, ALQUILTIO, ALQUILSULFINILO, ALQUILSULFONILO, TRIFLUOROMETILTIO, TRIFLUOROMETOXI O TRIFLUOROACETILO, CON LA CONDICION DE QUE CUANDO X O Y ES N,ENTONCES R3 Y R4 SON HIDROGENO, TRIFLUOROMETILO O ALQUILO; OBTENIDOS POR HACER REACCIONAR UN COMPUESTO DE FORMULA (IIB), DONDE W ES -CN O -C:S(NH2), CON UN COMPUESTO DE FORMULA (III), DONDE B ESF, CL, BR, I, SCN U OSO2R7 DONDE R7 ES ALQUILO, FENILO, METILFENILO, NITROFENILO O BROMOFENILO, EN PRESENCIA DE SULFURO DE HIDROGENO, CON LA CONDICION DE QUE CUANDO W ES CN, LA REACCION SE LLEVAA CABO EN PRESENCIA DEÑ UNA AMINA TERCIARIA.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US07/350,997 US4954629A (en) | 1989-05-11 | 1989-05-11 | Process and intermediates for the preparation of oxophthalazinyl acetic acids and analogs thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR246968A1 true AR246968A1 (es) | 1994-10-31 |
Family
ID=23379152
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AR90316824A AR246968A1 (es) | 1989-05-11 | 1990-05-10 | Procedimiento y compuestos utiles como intermediarios,que no poseen actividad terapeutica en seres humanos y animales superiores,para la separacion de acidos oxoftalazinil-aceticos y sus analogos |
Country Status (30)
| Country | Link |
|---|---|
| US (1) | US4954629A (es) |
| EP (1) | EP0397350B1 (es) |
| JP (1) | JPH035479A (es) |
| KR (1) | KR920006419B1 (es) |
| CN (1) | CN1025855C (es) |
| AR (1) | AR246968A1 (es) |
| AT (1) | ATE103913T1 (es) |
| AU (2) | AU618898B2 (es) |
| BG (1) | BG50609A3 (es) |
| CA (1) | CA2016504C (es) |
| CZ (1) | CZ281213B6 (es) |
| DD (1) | DD294257A5 (es) |
| DE (1) | DE69007846T2 (es) |
| DK (1) | DK0397350T3 (es) |
| EG (1) | EG19082A (es) |
| ES (1) | ES2063265T3 (es) |
| FI (1) | FI93959C (es) |
| HU (1) | HU212304B (es) |
| IE (1) | IE62591B1 (es) |
| IL (3) | IL94301A (es) |
| MX (2) | MX167455B (es) |
| NO (1) | NO177708C (es) |
| NZ (1) | NZ233597A (es) |
| PH (1) | PH26567A (es) |
| PL (1) | PL164427B1 (es) |
| PT (1) | PT93985B (es) |
| RO (1) | RO107256B1 (es) |
| RU (1) | RU2014333C1 (es) |
| YU (1) | YU91290A (es) |
| ZA (1) | ZA903565B (es) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4996204A (en) * | 1989-05-11 | 1991-02-26 | Pfizer Inc. | Pyrido[2,3-d]pyridazinones as aldose reductase inhibitors |
| IL124236A (en) * | 1997-05-05 | 2003-01-12 | Pfizer | Pharmaceutical composition for treating or reversing diabetic cardiomyopathy comprising aldose reductase inhibitor |
| EP0982306A3 (en) * | 1998-08-21 | 2000-07-05 | Pfizer Products Inc. | Polymorph of zopolrestat monohydrate |
| PT3597650T (pt) | 2010-07-16 | 2022-12-16 | Univ Columbia | Inibidores da aldose redutase e utilizações dos mesmos |
| US8916563B2 (en) | 2010-07-16 | 2014-12-23 | The Trustees Of Columbia University In The City Of New York | Aldose reductase inhibitors and uses thereof |
| CN102558184B (zh) * | 2011-12-30 | 2014-07-16 | 西南大学 | 酞嗪类衍生物的合成方法 |
| CN102702108A (zh) * | 2012-06-27 | 2012-10-03 | 上海大学 | 1,2-二氢酞嗪类化合物及其合成方法 |
| CN102863393A (zh) * | 2012-09-26 | 2013-01-09 | 上海大学 | 1,2-二氢酞嗪类化合物及其合成方法 |
| IL283809B2 (en) | 2016-06-21 | 2024-01-01 | Univ Columbia | Compounds for use in a method for treating neuropathy, retinopathy, nephropathy or cardiomyopathy |
| AU2018307964B2 (en) | 2017-07-28 | 2023-11-16 | Applied Therapeutics Inc. | Compositions and methods for treating galactosemia |
| BR112021019596A2 (pt) | 2019-04-01 | 2021-11-30 | Applied Therapeutics Inc | Inibidores de aldose redutase |
| JP2022531466A (ja) | 2019-05-07 | 2022-07-06 | ユニバーシティ オブ マイアミ | 遺伝性ニューロパチーおよび関連障害の処置および検出 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IE47592B1 (en) * | 1977-12-29 | 1984-05-02 | Ici Ltd | Enzyme inhibitory phthalazin-4-ylacetic acid derivatives, pharmaceutical compositions thereof,and process for their manufacture |
| DE3337859A1 (de) * | 1983-01-21 | 1984-07-26 | Bayer Ag, 5090 Leverkusen | Verfahren zur herstellung von benzthiazolen |
| CA1299178C (en) * | 1985-11-07 | 1992-04-21 | Banavara Lakshmana Mylari | Heterocyclic oxophtalazinyl acetic acids |
| IL80475A (en) * | 1985-11-07 | 1993-01-31 | Pfizer | Heterocyclic-substituted 4-oxo (or thio)-3h- phthalazinyl-acetic acid derivatives and pharmaceutical compositions containing them |
| JPH0676391B2 (ja) * | 1987-06-09 | 1994-09-28 | フアイザー・インコーポレイテツド | ベンゾチアゾール等の複素環側鎖を有するオキソフタラジニル酢酸類の製造方法 |
| EP0322153A3 (en) * | 1987-12-21 | 1990-08-16 | Pfizer Inc. | Heterocyclic oxophtalazinyl acetic acids |
| WO1989006651A1 (en) * | 1988-01-19 | 1989-07-27 | Pfizer Inc. | 1h-indazole-3-acetic acids as aldose reductase inhibitors |
| US4996204A (en) * | 1989-05-11 | 1991-02-26 | Pfizer Inc. | Pyrido[2,3-d]pyridazinones as aldose reductase inhibitors |
-
1989
- 1989-05-11 US US07/350,997 patent/US4954629A/en not_active Expired - Lifetime
-
1990
- 1990-04-25 EP EP90304441A patent/EP0397350B1/en not_active Expired - Lifetime
- 1990-04-25 DK DK90304441.0T patent/DK0397350T3/da active
- 1990-04-25 ES ES90304441T patent/ES2063265T3/es not_active Expired - Lifetime
- 1990-04-25 AT AT90304441T patent/ATE103913T1/de not_active IP Right Cessation
- 1990-04-25 DE DE69007846T patent/DE69007846T2/de not_active Expired - Fee Related
- 1990-05-02 RO RO144965A patent/RO107256B1/ro unknown
- 1990-05-04 IE IE162690A patent/IE62591B1/en not_active IP Right Cessation
- 1990-05-06 IL IL9430190A patent/IL94301A/en not_active IP Right Cessation
- 1990-05-06 IL IL114271A patent/IL114271A/en not_active IP Right Cessation
- 1990-05-08 CZ CS902278A patent/CZ281213B6/cs not_active IP Right Cessation
- 1990-05-08 NZ NZ233597A patent/NZ233597A/en unknown
- 1990-05-09 PT PT93985A patent/PT93985B/pt not_active IP Right Cessation
- 1990-05-09 PL PL90285113A patent/PL164427B1/pl unknown
- 1990-05-10 FI FI902333A patent/FI93959C/fi not_active IP Right Cessation
- 1990-05-10 AU AU54906/90A patent/AU618898B2/en not_active Ceased
- 1990-05-10 EG EG27690A patent/EG19082A/xx active
- 1990-05-10 CN CN90102797A patent/CN1025855C/zh not_active Expired - Fee Related
- 1990-05-10 KR KR1019900006579A patent/KR920006419B1/ko not_active IP Right Cessation
- 1990-05-10 AR AR90316824A patent/AR246968A1/es active
- 1990-05-10 DD DD90340590A patent/DD294257A5/de not_active IP Right Cessation
- 1990-05-10 RU SU904743977A patent/RU2014333C1/ru active
- 1990-05-10 ZA ZA903565A patent/ZA903565B/xx unknown
- 1990-05-10 HU HU902995A patent/HU212304B/hu not_active IP Right Cessation
- 1990-05-10 NO NO902071A patent/NO177708C/no not_active IP Right Cessation
- 1990-05-10 BG BG091982A patent/BG50609A3/xx unknown
- 1990-05-10 YU YU91290A patent/YU91290A/sh unknown
- 1990-05-10 CA CA002016504A patent/CA2016504C/en not_active Expired - Fee Related
- 1990-05-11 JP JP2122862A patent/JPH035479A/ja active Granted
- 1990-05-11 PH PH40512A patent/PH26567A/en unknown
- 1990-05-11 MX MX020672A patent/MX167455B/es unknown
-
1991
- 1991-10-28 AU AU86806/91A patent/AU626225B2/en not_active Ceased
-
1992
- 1992-12-31 MX MX9207687A patent/MX9207687A/es not_active IP Right Cessation
-
1995
- 1995-06-22 IL IL11427195A patent/IL114271A0/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR246968A1 (es) | Procedimiento y compuestos utiles como intermediarios,que no poseen actividad terapeutica en seres humanos y animales superiores,para la separacion de acidos oxoftalazinil-aceticos y sus analogos | |
| TW325468B (en) | Process for making phenyl heterocycles useful as cox-2 inhibitors | |
| AR241411A1 (es) | DERIVADOS DE°(VINIL,SULFO O TIOSULFONIL)-FENILO O NAFTILç-AZO-°8-¡(VINIL, SULFO O TIOFONIL FENILAMINO-(HALOGENO-5-TRIAZINIL)-AMINO¿-DISULFONAFTOL. | |
| EA199800579A1 (ru) | Новые производные 5-амино-3-циано-4-этилсульфинил-1-фенилпиразола и их применение в качестве пестицидов | |
| PE20030199A1 (es) | Derivados de n-[benzoil]-fenilsulfonamida | |
| DK0869946T3 (da) | Phenylimidazolidiner og deres anvendelse som anti-androgent middel | |
| ES2162367T3 (es) | Metodo de produccion de un compuesto de aminobenceno. | |
| DE69703935D1 (de) | 2-chloro-3,5-bis(trifluoromethyl)phenyl-benzoylharnstoff-derivate und verfahren zur herstellung derselben | |
| CO4960656A1 (es) | Derivados del 2-(4-aril o heteroaril-piperazin-1-ilmetil)1h- indol | |
| ES2026669T3 (es) | Procedimiento para la preparacion y el uso terapeutico de los beta-d-fenil tioxilosidos. | |
| AR245698A1 (es) | Procedimiento para preparar acidos 2-fenil-4-quinolincarboxilicos substituidos. | |
| ES2134837T3 (es) | N-((pirimidin-2-il)aminocarbonil)benzosulfonamidas herbicidas. | |
| HUP0200144A2 (hu) | Eljárás peszticid hatású 5-amino-1-aril-3-cianopirazol-származékok előállítására és az új köztitermékek | |
| AR248126A1 (es) | Nuevos derivados sustituidos de bicicloheptanodiona, procedimiento para obtenerlos y composiciones herbicidas que los contienen. | |
| BR0114753A (pt) | Processo para a preparação de compostos de bis-benzazolila | |
| ES2058150T3 (es) | Procedimiento para la obtencion de productos de reaccion del 2,2-bis(4-hidroxifenil)hexafluorpropano asi como estos nuevos derivados. | |
| DK1131307T3 (da) | Fremgangsmåde til fremstilling af 2-alkyl-3-(4,5-dihydroisoxal-3-yl)-halogenbenzoler | |
| DE60104380D1 (de) | Verfahren zur Herstellung von N-[1-(S)-Ethoxycarbonyl-3-phenylpropyl]-L-alanin-N-carboxyanhydrid | |
| AR247553A1 (es) | Procedimiento de preparacion de los acidos 4-oxo-3-quinolincarboxilicos utiles como agentes antibacterianos | |
| ATE78474T1 (de) | Verfahren zur herstellung von pyrimidinderivaten. | |
| PE86698A1 (es) | Derivados de indolina | |
| ATE118488T1 (de) | Benzothiadiazepin-derivate. | |
| MY130817A (en) | Herbicides | |
| AR005545A1 (es) | Un procedimiento para la preparacion de derivados de imidazodiacepina. | |
| PT96805A (pt) | Processo para a preparacao de 2,4,8-tri-substituido-3h,6h-1,4,5a,8a-tetra-aza-acenaftileno-3,5-(4h)-dionas |